Prevalence and risk factors of asthma and allergy-related diseases among adolescents (PERFORMANCE) study: rationale and methods

Bhattacharjee, Soumya; Haldar, Prasun; Gopal Maity, Santi; Debnath, Smriti; Moitra, Saibal; Saha, Sujoy; Mitra, Ritabrata; Annesi-Maesano, Isabella; García Aymerich, Judith; Moitra, Subhabrata

doi:http://dx.doi.org/10.1183/23120541.00034-2018

Prevalence and risk factors of asthma and allergy-related diseases among adolescents (PERFORMANCE) study: rationale and methods

Llicència

Citació

Bhattacharjee S, Haldar P, Gopal S, Debnath S, Moitra S, Saha S, et al. Prevalence and risk factors of asthma and allergy-related diseases among adolescents (PERFORMANCE) study: rationale and methods. ERJ Open Research. 2018 May;4(2):1-8. DOI: 10.1183/23120541.00034-2018

Resum

Despite a considerable number of international reports on allergic diseases among children, information about the prevalence and risk factors of asthma and allergy-related diseases among Indian adolescents is relatively sparse. The Prevalence and Risk Factors of Asthma and Allergy-Related Diseases among Adolescents (PERFORMANCE) study has been conceived to study the aetiology of asthma and allergic diseases including rhinoconjunctivitis, atopic eczema and food allergies among adolescents in West Bengal, India, using standardised methods and collaborations. The aims of the study are: 1) to estimate the prevalence and risk factors of asthma and allergic diseases among the adolescents residing in rural, suburban and urban areas of West Bengal; 2) to obtain information about the possible role of lifestyle factors (smoking, diet and physical activity) on the disease prevalence; and 3) to create a network for further investigation on social, environmental and genetic factors affecting the diseases. The PERFORMANCE study comprises two phases. The phase I study will investigate the prevalence and possible contributing factors of asthma and allergic diseases in a defined population. The phase II study will be performed as a follow-up of phase I to assess the incidence of asthma and allergic diseases.